These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32664570)

  • 1. Polymorphic Forms of Valinomycin Investigated by NMR Crystallography.
    Czernek J; Brus J
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining Nuclear Magnetic Resonance Spectroscopy and Density Functional Theory Calculations to Characterize Carvedilol Polymorphs.
    Rezende CA; San Gil RAS; Borré LB; Pires JR; Vaiss VS; Resende JALC; Leitão AA; De Alencastro RB; Leal KZ
    J Pharm Sci; 2016 Sep; 105(9):2648-2655. PubMed ID: 26372719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 13C NMR chemical shifts of the triclinic and monoclinic crystal forms of valinomycin.
    Kameda T; McGeorge G; Orendt AM; Grant DM
    J Biomol NMR; 2004 Jul; 29(3):281-8. PubMed ID: 15213426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17O solid-state NMR as a sensitive probe of hydrogen bonding in crystalline and amorphous solid forms of diflunisal.
    Vogt FG; Yin H; Forcino RG; Wu L
    Mol Pharm; 2013 Sep; 10(9):3433-46. PubMed ID: 23822557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the Site-Specific Solid-State NMR Data in Oligopeptides.
    Czernek J; Brus J
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valinomycin-proton interaction in low-polarity media.
    Kríz J; Dybal J; Makrlík E
    Biopolymers; 2006 Aug; 82(5):536-48. PubMed ID: 16538664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical investigation of hydroxylated analogues of valinomycin as potassium transporter.
    Sessa L; Concilio S; Marrafino F; Sarkar A; Diana R; Piotto S
    Comput Biol Chem; 2023 Oct; 106():107936. PubMed ID: 37523834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modelling of the antiviral action of Resveratrol derivatives against the activity of two novel SARS CoV-2 and 2019-nCoV receptors.
    Ranjbar A; Jamshidi M; Torabi S
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7834-7844. PubMed ID: 32744711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds.
    Ton AT; Gentile F; Hsing M; Ban F; Cherkasov A
    Mol Inform; 2020 Aug; 39(8):e2000028. PubMed ID: 32162456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and lung pathology.
    Jain A
    Indian J Pathol Microbiol; 2020; 63(2):171-172. PubMed ID: 32317509
    [No Abstract]   [Full Text] [Related]  

  • 12. Does Z' equal 1 or 2? Enhanced powder NMR crystallography verification of a disordered room temperature crystal structure of a p38 inhibitor for chronic obstructive pulmonary disease.
    Widdifield CM; Nilsson Lill SO; Broo A; Lindkvist M; Pettersen A; Svensk Ankarberg A; Aldred P; Schantz S; Emsley L
    Phys Chem Chem Phys; 2017 Jun; 19(25):16650-16661. PubMed ID: 28621371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus Disease and Acute Vascular Events.
    Rao GHR
    Clin Appl Thromb Hemost; 2020; 26():1076029620929091. PubMed ID: 32735130
    [No Abstract]   [Full Text] [Related]  

  • 14. Pandemic Pandemonium: Pausing Clinical Research During the COVID-19 Outbreak.
    Byrd JB; Bello N; Meyer MN
    Circulation; 2020 Jun; 141(25):2045-2047. PubMed ID: 32320272
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver injury in COVID-19: management and challenges.
    Zhang C; Shi L; Wang FS
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):428-430. PubMed ID: 32145190
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates.
    Yoshino R; Yasuo N; Sekijima M
    Sci Rep; 2020 Jul; 10(1):12493. PubMed ID: 32719454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-state (185/187)Re NMR and GIPAW DFT study of perrhenates and Re2(CO)10: chemical shift anisotropy, NMR crystallography, and a metal-metal bond.
    Widdifield CM; Perras FA; Bryce DL
    Phys Chem Chem Phys; 2015 Apr; 17(15):10118-34. PubMed ID: 25790263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New York City Innocence Lost: Cardiology in the COVID-19 Pandemic.
    Narula N; Singh HS
    Circulation; 2020 Jun; 141(25):2039-2041. PubMed ID: 32255370
    [No Abstract]   [Full Text] [Related]  

  • 19. Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies.
    Sarkar M; Saha S
    PLoS One; 2020; 15(8):e0237300. PubMed ID: 32785274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of combined solid-state NMR and DFT calculations for the study of piracetam polymorphism.
    Szeleszczuk Ł; Pisklak DM; Gubica T; Matjakowska K; Kaźmierski S; Zielińska-Pisklak M
    Solid State Nucl Magn Reson; 2019 Feb; 97():17-24. PubMed ID: 30508738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.